Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018 - MarketsandMarkets

Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018

Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018 - MarketsandMarkets
Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018
Published Jul 05, 2013
171 pages — Published Jul 05, 2013
Price US$ 4,650.00  |  Buy this Report Now

About This Report

  
Abstract:

Aptamers is an emerging market, widely considered as a rival or substitute to antibodies in the scientific industry. It is poised to grow rapidly in various application areas, including therapeutics and diagnostics. The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018.

Aptamers existed in parallel with antibodies for two decades, but its market potential was not utilized, even to a fraction of antibodies. However, the achievement of Macugen has given a boost to the aptamer field. The list of promising aptamers in the clinical trials pipeline estimates that these synthetic chemical antibodies will soon surpass monoclonal antibodies in therapeutics, diagnosis, and imaging. With technological merits over antibodies, the aptamers market is poised to grow at par with antibodies in the next 10-15 years.

Though there are just < 60 companies (biotech and pharmaceutical) working on aptamers, there are quite a number of research groups working on diverse applications of aptamers, particularly in studying key target molecules involved in cardiovascular diseases, infectious diseases, and against viral antigens. Hundreds of research articles have been published and a lot of patents granted and filed for this technology.

The aptamers market is analyzed both in terms of qualitative, i.e. technological and quantitative, i.e. revenue, perspectives. The technological analysis includes discussion on inherent characteristics and capabilities of aptamers over antibodies and the various applications where aptamers can find its place. The market revenue analysis includes market segmentation and the expected market position by 2018, with the projected growth rate.

The aptamers market is classified by geography, application segments and aptamer type. The application segments are further divided as therapeutics, diagnostics, biosensors, drug discovery, biomarker discovery, and research applications. The advantages of chemically modified aptamers and low production cost compared to antibodies aid the growth of the market. However, the reduced market acceptance compared to the antibodies and increased time consumption for screening using SELEX will hamper the growth of this market, to a certain extent. While aptamer technology has existed for over two decades, the challenges imposed on the development of aptamers for small molecules has resulted in very few novel aptamers that can bind to practical small molecular targets. Nevertheless, there are many opportunities for the innovative application of small molecule binding aptamers in biosensing, drug discovery, diagnostics and therapeutics.

Besides a discussion on the properties of aptamers in the technological analysis, the basics on nucleic acid aptamers, peptide aptamers and the SELEX method for their synthesis are also discussed. Research applications are specifically discussed regarding aptamers use in flow cytometry, reagents and assays, mass spectrometry and western blotting. In addition, a number of therapeutic targets that are validated by basic research have been displayed under the therapeutics application segment. The complete value chain of the aptamers market is schematically represented and the significance of each stakeholder has been briefed.

Apart from the technological and market analysis, the investor climate has been assessed by tracking the complete investor network and collecting data on funds/grants and investments made towards the aptamers. Insights on current and future technological investment trends have also been discussed.

The adoption and developmental potential of the aptamers technology market has been discussed on a geographic basis, i.e. North America, Europe, Asia-Pacific, and Rest of the world, by taking select countries that are poised to have a greater

  
Source:
Document ID
BT 2018
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
Table Of Content

1 Introduction (Slide No- 18)
1.1 Logical Assumptions In This Study Based On Reliable Sources
1.2 Key Take-Aways
1.3 Report Scope
1.4 Research Methodology
1.5 Key Data Points From Secondary And Primary Sources

2 Executive Summary (Slide No- 25)

3 Aptamers - Technology Landscape Analysis (Slide No- 29)
3.1 Technology Overview
3.2 History & Milestones Of Aptamers
3.3 Aptamers Vs Antibodies
3.4 Aptamer Types
3.4.1 Nucleic Acid Aptamers
3.4.2 Peptide Aptamers
3.5 Aptamer Synthesis & Modifications
3.6 Applications
3.6.1 Therapeutics
3.6.1.1 Different Targets Of Therapeutic Interest
3.6.2 Diagnostics
3.6.3 Biosensors
3.6.4 Drug Discovery
3.6.5 Biomarker Discovery
3.6.6 Research Applications
3.6.6.1 Reagents & Assays
3.6.6.2 Flow Cytometry
3.6.6.3 Mass Spectrometry
3.6.6.4 Western Blotting
3.7 Technology Value Chain Analysis
3.8 Aptamers - Technology Innovations And Products With Applications

4 Aptamers - Market Landscape Analysis (Slide No- 56)
4.1 Aptamers Market Segmentation
4.2 Aptamers Technology - Global Impact
4.3 Market Forecast (2013 - 2018) - Overview
4.4 Global Aptamers Market Revenue Forecast (2013-2018)
4.4.1 Global Aptamers Market Revenue - By Geography
4.4.1.1 North America
4.4.1.2 Europe
4.4.1.3 Asia Pacific
4.4.1.4 Rest Of The World
4.4.2 Global Aptamers Market Share - By Geography
4.4.2.1 North America
4.4.2.2 Europe
4.4.2.3 Asia Pacific
4.4.2.4 Rest Of The World
4.4.3 Global Aptamers Market Revenue - By Application Segments
4.4.3.1 Global Aptamers Market Share - By Segments
4.4.3.2 Therapeutic Aptamers Market - By Region
4.4.3.3 Diagnostics Aptamers Market - By Region
4.4.3.4 Biosensors Aptamers Market - By Region
4.4.3.5 Drug Discovery Aptamers Market - By Region
4.4.3.6 Aptamers Biomarker Discovery Market - By Region
4.4.3.7 Aptamers Research Applications Market - By Region
4.4.4 Global Aptamers Market Revenue - By Aptamer Type
4.4.4.1 Nucleic Acid Aptamer Market - By Region
4.4.4.2 Peptide Aptamer Market - By Region
4.4.4.3 Nucleic Acid And Peptide Aptamers Market Share - By Region
4.5 Market Dynamics
4.5.1 Drivers - Explanation
4.5.1.1 Impact Analysis By Timeline
4.5.2 Restraints - Explanation
4.5.2.1 Impact Analysis By Timeline
4.6 SWOT Analysis
4.7 Porter's Five Forces Analysis

5 Technology Investment Potential (Slide No- 92)
5.1 Investment Climate Assessment
5.2 Investor Network
5.3 Some Funds And Investments On Aptamers
5.4 Some Funds And Investments From Nih - By Fiscal Year
5.5 Some Funds And Investments From Nih - By Its Associated Institutes/Centers (FY 2008-2013)
5.6 Insights On Current And Future Tech-Investment Trends

6 Aptamers - Technology Adoption And Development Potential (Slide No- 104)
6.1 Geographic Adoption And Development Potential - Overview
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Row - Selected Countries
6.6 Demand Side Analysis
6.7 Technology

Table Of Contents

MarketsandMarkets—Worldwide, market research reports primarily sold for numbers, market segmentation and competitive landscape, within the business leaders.

About the Author


Cite this Report

  
MLA:
MarketsandMarkets. "Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018" Jul 05, 2013. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/MarketsandMarkets/Aptamers-Market-Technology-Trend-Analysis-By-Applications-Therapeutics-Diagnostics-Biosensors-Drug-Discovery-Biomarker-Discovery-Research-Applications-with-Market-Landscape-Analysis-Global-Forecasts-to-2018-2144-177>
  
APA:
MarketsandMarkets. (2013). Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018 Jul 05, 2013. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/MarketsandMarkets/Aptamers-Market-Technology-Trend-Analysis-By-Applications-Therapeutics-Diagnostics-Biosensors-Drug-Discovery-Biomarker-Discovery-Research-Applications-with-Market-Landscape-Analysis-Global-Forecasts-to-2018-2144-177>
  
US$ 4,650.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.